Genome
PrivateMomentum
Top 5%
of companies Caplight tracks
Company Overview
Genome operates in FinTech and is based in Vilnius. It was founded in 2018.
Genome is a fintech company that provides an all-in-one financial ecosystem offering personal and business IBAN accounts, payment processing, and currency exchange services.
Sector
FinTech
Verticals
Digital Banking, Digital Payments, Corporate Banking, Foreign Exchange, Personal Finance
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genome Comparables
Compare Genome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VIALET | 88% | |
| 3S Money | 78% | |
| Juni | 78% |
For institutional investors. Book with your work email.
Genome Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 47, 33% of headcount.
- Aug 31, 2026
Open roles increased to 17, 2.1x the trailing average.
For institutional investors. Book with your work email.
Genome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genome's valuation, stock price, and market status.
Is Genome a public or private company?
Genome is a private company.
What is the current stock price of Genome?
Genome is a private company, so its shares have no public market price. Caplight tracks Genome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genome worth (valuation)?
Valuation information for Genome is not publicly available.
Can I buy Genome stock?
Genome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genome's last funding round?
Funding round information for Genome is not publicly available.
Who are the main investors in Genome?
Investor information for Genome is not publicly disclosed.
Will Genome IPO soon?
No public IPO plans have been announced for Genome.
How can I track Genome secondary market activity?
Caplight tracks bids, offers, and trades in Genome's shares on secondary markets.